首页> 外文期刊>Andrologia >Patients with multiple morphological abnormalities of the sperm flagella harbouring CFAP44 or CFAP43 mutations have a good pregnancy outcome following intracytoplasmic sperm injection
【24h】

Patients with multiple morphological abnormalities of the sperm flagella harbouring CFAP44 or CFAP43 mutations have a good pregnancy outcome following intracytoplasmic sperm injection

机译:患有CFAP44或CFAP43突变的精子鞭毛的多种形态异常的患者具有良好的妊娠结束后患有血晶体精子注射

获取原文
获取原文并翻译 | 示例
       

摘要

Multiple morphological abnormalities of the sperm flagella (MMAF) are a rare type of male infertility. Mutations in DNAH1, CFAP43 and CFAP44 are the main aetiology of the disorder. Previously, good intracytoplasmic sperm injection (ICSI) outcomes were reported for MMAF patients with DNAH1 mutations. However, the ICSI prognosis for MMAF patients with CFAP43 or CFAP44 mutations was not known. We designed a retrospective cohort study. Molecular genetic testing identified six MMAF patients with biallelic CFAP44 (CFAP44(+) group) or CFAP43 mutations and 12 patients with homozygous or compound heterozygous DNAH1 mutations (DNAH1(+) group). A control group consisted of age-matched, non-MMAF men. For MMAF patients carrying CFAP44 mutations, the recorded rates of fertilisation, transferable embryos, pregnancy and delivery after ICSI were 76.47%, 88.46%, 50.0% and 50.0% respectively. The fertilisation rate was significantly higher in the CFAP44(+) group than in the DNAH1(+) group (76.47% vs. 54.5%, p = 0.0196). There were no statistically significant differences in the rates of transferable embryos, implantation, clinical pregnancy and miscarriage between the CFAP44(+) group and either the DNAH1(+) group or the age-matched control group. Our results support a good ICSI prognosis for MMAF patients carrying CFAP44 or CFAP43 mutations.
机译:精子鞭毛(MMAF)的多种形态异常是一种罕见的男性不孕症。 DNAH1,CFAP43和CFAP44中的突变是该疾病的主要病症。以前,据报道了MMAF患者的DNAH1突变患者良好的血液节粒体精子注射液(ICSI)结果。然而,不知道MMAF患者的ICSI预后或CFAP44突变的预后。我们设计了一个回顾性的队列研究。分子遗传学检测鉴定了六种MMAF患者的双思考CFAP44(CFAP44(+)组)或CFAP43突变和12例纯合或化合物杂合性DNAH1突变(DNAH1(+)组)。对照组由年龄匹配的非MMAF男性组成。对于携带CFAP44突变的MMAF患者,ICSI后的受精,可转移胚胎,妊娠和递送的记录率分别为76.47%,88.46%,50.0%和50.0%。 CFAP44(+)组中的施肥率明显高于DNAH1(+)组(76.47%对54.5%,P = 0.0196)。 CFAP44(+)组与DNAH1(+)组或年龄匹配对照组之间的可转移胚胎,植入,临床妊娠和流产率没有统计学上显着的差异。我们的研究结果支持携带CFAP44或CFAP43突变的MMAF患者的良好ICSI预后。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号